New Leaf Venture Partners’s Passage Bio PASG Stock Holding History

New Leaf Venture Partners’s Portfolio PASG Stock Details PASG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$702K	Sell	87,426 -37,470	-30%	-$261K	1.63%	7
2025 Q2	$20M	Hold	124,896	–	–	37.74%	1
2025 Q1	$882K	Hold	124,896	–	–	1.96%	7
2024 Q4	$1.42M	Hold	124,896	–	–	1.89%	7
2024 Q3	$1.75M	Hold	124,896	–	–	1.8%	7
2024 Q2	$1.98M	Hold	124,896	–	–	2.41%	7
2024 Q1	$3.37M	Hold	124,896	–	–	2.95%	6
2023 Q4	$2.52M	Hold	124,896	–	–	2.03%	9
2023 Q3	$1.65M	Hold	124,896	–	–	2.12%	9
2023 Q2	$2.35M	Hold	124,896	–	–	2.02%	9
2023 Q1	$2.4M	Hold	124,896	–	–	1.98%	8
2022 Q4	$3.45M	Hold	124,896	–	–	2.5%	7
2022 Q3	$3.12M	Hold	124,896	–	–	1.85%	8
2022 Q2	$5.89M	Hold	124,896	–	–	3.82%	8
2022 Q1	$7.74M	Hold	124,896	–	–	3.82%	7
2021 Q4	$15.9M	Hold	124,896	–	–	5.75%	5
2021 Q3	$24.9M	Hold	124,896	–	–	7.18%	6
2021 Q2	$1.47M	Hold	124,896	–	–	0.38%	18
2021 Q1	$43.7M	Hold	124,896	–	–	10.16%	5
2020 Q4	$63.9M	Hold	124,896	–	–	14.76%	3
2020 Q3	$32.7M	Hold	124,896	–	–	13.19%	4
2020 Q2	$68.3M	Hold	124,896	–	–	19.59%	3
2020 Q1	$39.3M	Buy	+124,896	New	+$39.1M	11.77%	3

Other funds holding PASG

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

New Leaf Venture Partners's PASG Position: Q3 2025 in Review

New Leaf Venture Partners reduced its Passage Bio (PASG) stake by 30% in Q3 2025, selling an estimated $261K and leaving 87,426 shares worth $702K. The position accounts for 1.63% of the portfolio, ranked #7.

New Leaf Venture Partners first reported a position in PASG in Q1 2020 and has held it in 23 quarters since. The position peaked at $68.3M in Q2 2020. 32 funds tracked by Wall St. Rank hold PASG as of Q3 2025.

New Leaf Venture Partners held 87,426 shares of Passage Bio worth $702K as of Q3 2025.
New Leaf Venture Partners sold 37,470 Passage Bio shares in Q3 2025, an estimated $261K.
Passage Bio made up 1.63% of New Leaf Venture Partners's portfolio in Q3 2025, its #7 holding.
New Leaf Venture Partners first reported a position in Passage Bio in Q1 2020 and has held it in 23 quarters since.
New Leaf Venture Partners's Passage Bio position peaked at $68.3M in Q2 2020.
32 funds tracked by Wall St. Rank held Passage Bio as of Q3 2025.

Based on New Leaf Venture Partners's 13F filing for Q3 2025, filed 14 Nov 2025.